Select Topic:
Browse by Series:

QUAZAR: Oral Azacitidine Maintenance in AML

Panelists: Harry Erba, MD, PhD, Duke Cancer Institute; Naval Daver, MD, The University of Texas MD Anderson Cancer Center; Rami Komrokji, MD, H. Lee Moffitt Cancer Center; Mark Levis, MD, PhD, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center; Dan Pollyea, MD, MS, University of Colorado Cancer Center
Published: Thursday, Feb 13, 2020



Transcript:

SELECTED
LANGUAGE
Slider Left
Slider Right


Transcript:
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
x